Around the world, countries are racing to develop nationwide sequencing programs to address their specific health needs
In the fast-moving, ever-evolving field of medical microbiology, a team of scientists gets a boost from the new Illumina MiSeq i100
How Illumina’s Greg Davis ensures the new instrument is developed with manufacturability in mind
Collaborators at the University of Melbourne and Peter MacCallum Cancer Centre developing a liquid biopsy test for cancer of unknown primary
More than a quarter of cases in the Australian Cerebral Palsy Biobank traced to gene variation
| Date | Publication | Title |
|---|---|---|
| 28 Oct. 2024 | Nature | Clinical genome sequencing in patients with suspected rare genetic disease in Peru |
| 25 Oct. 2024 | Medical Device Network | GeneDx reveals new findings from newborn genetic screening study |
| 17 Oct. 2024 | fDi Intelligence | Illumina lights up Milan genomics |
| 16 Oct. 2024 | Genome Web | Illumina to Offer More Pillar Cancer Panels as Part of Expanded Partnership |
| 16 Oct. 2024 | GeneOnline | Illumina and NTU Hospital Sign Collaboration Agreement to Launch Large-Scale Whole Genome Sequencing Project |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
